Gregor Posted January 23, 2009 Share Posted January 23, 2009 Schoch et al. JISSN 3(1):60-66, 2006--06/23/2006AbstractSchoch, R.D., D. Willoughby, M. Greenwood. The regulation and expression of the creatine transporter: a brief review of creatine supplementation in humans and animals. Journal of the International Society of Sports Nutrition. 3(1): 60-65, 2006.RESPONDERS VS. NONRESPONDERSMost studies have reported an increase inintramuscular creatine levels withsupplementation; however, variability doesexist. This poses the possible scenario of“responders†versus “nonresponders†to creatinesupplementation. It is hypothesized that muchof this variability lies within the regulation andactivity of the creatine transporter.Unfortunately, most of the limited creatinesupplementation research conductedinvestigating the expression of CreaT has beenthrough animal models, as previously noted.Greenhaff et al observed that approximately 20-30%of participants following a creatine loadingregime did not respond with an increase inintracellular creatine 24 . This was defined asresting total muscle creatine levels less than10mmol/kg following a 5 day creatine loadingphase at 20g/d. Responders were then classifiedas achieving a 20mmol/kg increase followingthe loading phase. Recently, Syrotuik and Bell 25 conducted a descriptive profile of individualsportraying Greenhaff’s classification of“responder†and “non-responderâ€Âcharacteristics. Results of this study concludedthat the responders generally:1) possessed alower initial quantity of intramuscular creatineand were able to absorb and take up a greateramount through supplementation; 2) had agreater percentage of type II fibers; 3) had agreater fiber cross sectional area; and 4)possessed more fat-free mass. This datasuggests that an individual’s biological profilemay partially determine the efficacy of acreatine supplementation protocol. Link to comment Share on other sites More sharing options...
Recommended Posts